Systemic and tumor level iron regulation in men with colorectal cancer: A case control study

Nutrition and Metabolism

Volumn 11, Issue 1, 2014, Pages

  Pusatcioglu, Cenk K ^a   Nemeth, Elizabeta ^b   Fantuzzi, Giamila ^c   Llor, Xavier ^c   Freels, Sally ^c   Tussing Humphreys, Lisa ^c   Cabay, Robert J ^c   Linzmeier, Rose ^b   Ng, Damond ^b   Clark, Julia ^c   Braunschweig, Carol ^c  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anemia; Colorectal cancer; Hepcidin; Inflammation; Iron metabolism

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CYCLOOXYGENASE 2 INHIBITOR; FERROPORTIN; HEPCIDIN; INTERLEUKIN 6; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER STAGING; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DUODENUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; INFLAMMATION; IRON ABSORPTION; IRON BLOOD LEVEL; IRON INTAKE; IRON METABOLISM; IRON RESTRICTION; IRON STORAGE; IRON THERAPY; IRON TRANSPORT; MALE; MEDICAL HISTORY; REAL TIME POLYMERASE CHAIN REACTION; TRANSFERRIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84901694993     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-11-21     Document Type: Article

References (43)

1. Modulation of iron transport proteins in human colorectal carcinogenesis. Brookes MJ, Hughes S, Turner FE, Reynolds G, Sharma N, Ismail T, Berx G, McKie AT, Hotchin N, Anderson GJ, Iqbal T, Tselepis C, Gut 2006 55 1449 1460 10.1136/gut.2006.094060 16641131 (Pubitemid 44476791)
2. Iron: an emerging factor in colorectal carcinogenesis. Chua AC, Klopcic B, Lawrance IC, Olynyk JK, Trinder D, World J Gastroenterol WJG 2010 16 663 672 10.3748/wjg.v16.i6.663
3. Iron and colorectal cancer risk: human studies. Nelson RL, Nutr Rev 2001 59 140 148 11396694 (Pubitemid 32494626)
4. Body iron stores and risk of colonic neoplasia. Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall JW, Bowen P, J Natl Cancer Inst 1994 86 455 460 10.1093/jnci/86.6.455 8120921 (Pubitemid 24081879)
5. Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo. Radulescu S, Brookes MJ, Salgueiro P, Ridgway RA, McGhee E, Anderson K, Ford SJ, Stones DH, Iqbal TH, Tselepis C, Sansom OJ, Cell Reports 2012 2 270 282 10.1016/j.celrep.2012.07.003 22884366
6. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Toyokuni S, Cancer Sci 2009 100 9 16 10.1111/j.1349-7006.2008.01001.x 19018762
7. Regulation of iron metabolism by hepcidin. Nemeth E, Ganz T, Annu Rev Nutr 2006 26 323 342 10.1146/annurev.nutr.26.061505.111303 16848710
8. Immunoassay for human serum hepcidin. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M, Blood 2008 112 4292 4297 10.1182/blood-2008-02-139915 18689548
9. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. Tussing-Humphreys L, Pusatcioglu C, Nemeth E, Braunschweig C, J Acad Nutr Diet 2012 112 391 400 10.1016/j.jada.2011.08.038 22717199
10. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Ganz T, Blood 2003 102 783 788 10.1182/blood-2003-03-0672 12663437 (Pubitemid 36917762)
11. The role of hepcidin in iron metabolism. Nemeth E, Ganz T, Acta Haematol 2009 122 78 86 10.1159/000243791 19907144
12. Interacting signals in the control of hepcidin expression. Darshan D, Anderson GJ, Biometals Int J role Metal ions Biol Biochem Med 2009 22 77 87 10.1007/s10534-008-9187-y
13. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J, Science 2004 306 2090 2093 10.1126/science.1104742 15514116 (Pubitemid 40007660)
14. Ferroportin and iron regulation in breast cancer progression and prognosis. Pinnix ZK, Miller LD, Wang W, D'Agostino R Jr, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM, Sci Transl Med 2010 2 43 56
15. Increased hepcidin expression in colorectal carcinogenesis. Ward DG, Roberts K, Brookes MJ, Joy H, Martin A, Ismail T, Spychal R, Iqbal T, Tselepis C, World J Gastroenterol WJG 2008 14 1339 1345 10.3748/wjg.14.1339 (Pubitemid 351425211)
16. A dual-monoclonal sandwich ELISA specific for hepcidin-25. Butterfield AM, Luan P, Witcher DR, Manetta J, Murphy AT, Wroblewski VJ, Konrad RJ, Clin Chem 2010 56 1725 1732 10.1373/clinchem.2010.151522 20847326
17. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Sasu BJ, Li H, Rose MJ, Arvedson TL, Doellgast G, Molineux G, Blood Cells Mol Dis 2010 45 238 245 10.1016/j.bcmd.2010.07.013 20800515
18. Pathogenesis and treatment of anaemia of chronic disease. Weiss G, Blood Rev 2002 16 87 96 10.1054/blre.2002.0193 12127952 (Pubitemid 34742225)
19. Inflammation and colon cancer. Terzic J, Grivennikov S, Karin E, Karin M, Gastroenterology 2010 138 2101 2114 e2105 10.1053/j.gastro.2010.01.058 20420949
20. Preoperative anemia in colon cancer: assessment of risk factors. Dunne JR, Gannon CJ, Osborn TM, Taylor MD, Malone DL, Napolitano LM, Am Surg 2002 68 582 587 (Pubitemid 44897071)
21. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D, Eur J Cancer 2004 40 2293 2306 10.1016/j.ejca.2004.06.019 15454256 (Pubitemid 39348881)
22. Validation of a self-administered diet history questionnaire using multiple diet records. Block G, Woods M, Potosky A, Clifford C, J Clin Epidemiol 1990 43 1327 1335 10.1016/0895-4356(90)90099-B 2254769
23. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Edge SB, Compton CC, Ann Surg Oncol 2010 17 1471 1474 10.1245/s10434-010-0985-4 20180029
24. World Health Organization, Centers for Disease Control, Assessing the iron status of populations: Report of a joint WHO/CDC Technical Consultation on the assessment of iron status at the population level 2007 http://www.who.int/ nutrition/publications/micronutrients/anaemia-iron-deficiency/en/
25. An assessment of dried blood-spot technology for identifying iron deficiency. Cook JD, Flowers CH, Skikne BS, Blood 1998 92 1807 1813 9716612 (Pubitemid 28406888)
26. Elevated systemic hepcidin and iron depletion in obese premenopausal females. Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Guzman G, Holterman AX, Braunschweig C, Obesity 2010 18 1449 1456 10.1038/oby.2009.319 19816411
27. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Holterman AX, Galvani C, Ayloo S, Vitello J, Braunschweig C, Obesity 2010 18 2010 2016 10.1038/oby.2009.490 20075851
28. Prevalence of anemia in cancer patients undergoing radiation therapy. Harrison L, Shasha D, Shiaova L, White C, Ramdeen B, Portenoy R, Semin Oncol 2001 28 54 59 10.1053/sonc.2001.25399 (Pubitemid 32522239)
29. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Grotto HZ, Med Oncol 2008 25 12 21 10.1007/s12032-007-9000-8 18188710
30. Hepcidin and cytokines in anaemia. Means RT, Hematol 2004 9 357 362 10.1080/10245330400018540 (Pubitemid 40123584)
31. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM, Lancet 1996 348 1472 1477 10.1016/S0140-6736(96)03386-7 8942775 (Pubitemid 26400242)
32. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Huang H, Constante M, Layoun A, Santos MM, Blood 2009 113 3593 3599 10.1182/blood-2008-08-173641 19204324
33. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Aeberli I, Hurrell RF, Zimmermann MB, Int J Obes 2009 33 1111 1117 10.1038/ijo.2009.146
34. Serum hepcidin levels are associated with obesity but not liver disease. Vuppalanchi R, Troutt JS, Konrad RJ, Ghabril M, Saxena R, Bell LN, Kowdley KV, Chalasani N, Obesity 2013 22 836 841 23512600
35. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I, Hurrell RF, Int J Obes 2008 32 1098 1104 10.1038/ijo.2008.43 (Pubitemid 351986198)
36. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Young MF, Glahn RP, Ariza-Nieto M, Inglis J, Olbina G, Westerman M, O'Brien KO, Am J Clin Nutr 2009 89 533 538 10.3945/ajcn.2008.26589 19073788
37. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y, Gastroenterol 2006 131 788 796 10.1053/j.gastro.2006.07.007 (Pubitemid 44316823)
38. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H, Endocrinol 2007 148 2663 2668 10.1210/en.2006-1331 (Pubitemid 46984791)
39. Hepcidin regulation by BMP signaling in macrophages is lipopolysaccharide dependent. Wu X, Yung LM, Cheng WH, Yu PB, Babitt JL, Lin HY, Xia Y, PLoS One 2012 7 44622 10.1371/journal.pone.0044622 23028567
40. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y, Dig Dis Sci 2000 45 394 397 10.1023/A:1005437331967 10711457 (Pubitemid 30133904)
41. Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet. Seril DN, Liao J, Yang CS, Yang GY, Dig Dis Sci 2005 50 696 707 10.1007/s10620-005-2560-6 15844705 (Pubitemid 40558464)
42. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Malliaraki N, Sfiridaki A, Kouroumalis EA, Eur J Gastroenterol Hepatol 2011 23 262 268 10.1097/MEG.0b013e328343b885 21285884
43. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA a Cancer J Clin 2011 61 69 90 10.3322/caac.20107